Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege.

Source:http://linkedlifedata.com/resource/pubmed/id/15050916

Download in:

View as

General Info

PMID
15050916